Zembrace Symtouch
Product Images NDC 0245-0809

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Zembrace Symtouch (NDC 0245-0809). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zembrace 01)

Chemical structure diagram showing the molecular formula of the active ingredient associated with ZEMBRACE SYMTOUCH. The diagram includes functional groups such as sulfonamide, indole ring, and carboxylic acid moieties.*

FDA Label Image

Figure (Zembrace 02)

FDA Label Image

Figure (Zembrace 03)

An instructional diagram of the ZEMBRACE SYMTOUCH autoinjector device by Upsher-Smith Laboratories, LLC. The image labels the device components, including a red cap, yellow needle guard, medicine viewing window, and a red plunger rod, illustrating the parts of this injection system.*

FDA Label Image

Figure (Zembrace 04)

Illustration showing a close-up of an eye with a hand holding a syringe, indicating how to read the expiration date printed on the syringe barrel labeled 'EXP: Mo. / Yr.' along the side. The illustration highlights visual alignment for checking expiration details on the product.*

FDA Label Image

Figure (Zembrace 05)

Illustration showing a person holding a ZEMBRACE SYMTOUCH autoinjector device. A close-up of the device's viewing window is depicted, highlighting the indicator line within the window used to confirm proper injection.*

FDA Label Image

Figure (Zembrace 06)

An instructional illustration showing the ZEMBRACE SymTouch, a prefilled injection device with a red cap and viewing window. The image also depicts an alcohol swab, a sterile cotton ball or gauze pad, and a puncture-resistant sharps container labeled biohazard for safe disposal of the injection device.*

FDA Label Image

Figure (Zembrace 07)

An illustration diagram showing possible injection sites on a human body figure, including the upper arms, abdomen, and upper thighs. The locations are marked with green rectangles highlighting areas suitable for injection administration.*

FDA Label Image

Figure (Zembrace 08)

An instructional illustration showing a hand holding a small round object and applying it with a rubbing motion on a bent arm. Two curved arrows indicate the back-and-forth rubbing action on the skin surface.*

FDA Label Image

Figure (Zembrace 09)

An instructional illustration showing a hand holding the Zembrace SymTouch autoinjector with a zoomed-in inset highlighting the device's injection window. Another hand is removing the needle cap, indicated by an arrow pointing from the cap to the device, demonstrating how to prepare the autoinjector for use.*

FDA Label Image

Figure (Zembrace 10)

An illustration showing a hand holding a ZEMBRACE SYMTOUCH device with the tip applied to the skin, demonstrating usage technique for this injection system.*

FDA Label Image

Figure (Zembrace 11)

Instructional diagram showing how to use ZEMBRACE SYMTOUCH, including pressing the device down until a first click, holding it while pressing again until a second click, then waiting and slowly counting to five before releasing. The illustration uses hand graphics and text to guide the user.*

FDA Label Image

Figure (Zembrace 12)

An instructional diagram showing a hand holding a ZEMBRACE SYMTOUCH device with the yellow needle guard locked over the needle, indicated by an upward arrow. The image illustrates safe handling or preparation of the injection device.*

FDA Label Image

Figure (Zembrace 13)

An instructional diagram showing a hand holding the ZEMBRACE SYMTOUCH device near an eye. The image highlights proper eye alignment and positioning for using the device, indicated by a dashed line from the eye to the device's viewing window.*

FDA Label Image

Figure (Zembrace 14)

An instructional illustration showing a hand disposing of an injector pen into a red sharps container labeled with a biohazard symbol and the word 'BIOHAZARD'. The image indicates proper disposal of the ZEMBRACE SYMTOUCH injector device in a sharps container.*

FDA Label Image

Principal Display Panel (3 mg Syringe Carton)

Zembrace SymTouch 3 mg (sumatriptan injection) packaging label from Upsher-Smith Laboratories. The label shows storage instructions, including storing at 20° to 25°C and protection from light. It includes an illustration of the auto-injector pen and states that the product is for subcutaneous use only. The carton displays the NDC 0245-0809-38 and company information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.